Progeria Research Foundation

Grants will be awarded to research projects that are likely to lead to clinical treatment trials within five years, including the discovery and/or testing of candidate treatment compounds in cell-based or animal models of Hutchinson-Gilford Progeria Syndrome; the development of gene-, biomolecule-, drug-, and cell-based therapies to treat progeria; and/or assessments of the natural history of disease that may be important to developing outcome measures in treatment trials (preclinical or clinical).

Eligible applicants must hold a faculty appointment or equivalent.

Letters of Intent are due by January 3, 2022.